Stevanato Group (NYSE:STVN) Coverage Initiated at UBS Group

Investment analysts at UBS Group began coverage on shares of Stevanato Group (NYSE:STVN) in a report released on Wednesday, MarketBeat.com reports. The brokerage set a “neutral” rating on the stock.

STVN has been the topic of several other reports. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Finally, Wolfe Research started coverage on shares of Stevanato Group in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Stevanato Group Price Performance

STVN stock opened at €20.32 on Wednesday. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00. The business’s 50 day simple moving average is €20.44 and its 200 day simple moving average is €17.76. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $6.15 billion, a PE ratio of 36.29, a PEG ratio of 1.63 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The business had revenue of €302.00 million for the quarter. As a group, research analysts anticipate that Stevanato Group will post 0.71 EPS for the current year.

Insiders Place Their Bets

In other Stevanato Group news, Director Elisabetta Magistretti sold 2,045 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €41,084.05. Following the transaction, the director owned 2,930 shares in the company, valued at €58,863.70. This represents a 41.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William J. Federici sold 1,493 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director directly owned 26,991 shares in the company, valued at €461,276.19. This represents a 5.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 14,249 shares of company stock worth $268,346. 0.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Stevanato Group

Several institutional investors have recently made changes to their positions in STVN. State of Wyoming raised its holdings in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after acquiring an additional 2,353 shares in the last quarter. GW&K Investment Management LLC increased its position in shares of Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares during the period. Quantbot Technologies LP acquired a new position in Stevanato Group in the third quarter valued at about $68,000. Integrated Wealth Concepts LLC bought a new stake in Stevanato Group during the second quarter worth about $59,000. Finally, Fifth Third Bancorp increased its holdings in Stevanato Group by 22.6% in the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after buying an additional 773 shares during the period.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.